Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Elona Turley"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 6, Pp n/a-n/a (2021)
Abstract Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out
Externí odkaz:
https://doaj.org/article/1dad7fdb5a754d7c9ef91c4b7a9df202
Autor:
Yan Yuan, Yutian Wang, Amanda D VanSpronsen, Elona Turley, Valentin Villatoro, Laura Zychla, Arto Ohinmaa
Publikováno v:
American Journal of Clinical Pathology. 157:40-46
Objectives Choosing Wisely Canada (CWC) publishes practices that may contribute to medical overuse and patient harm. Many practices concern laboratory testing, but the recommendations are often written for the test-ordering professionals. Our objecti
Publikováno v:
Laboratory medicine. 54(1)
ObjectiveInappropriate laboratory test ordering is a significant and persistent problem. Many causes have been identified and studied. Medical laboratory professionals (MLPs) are technical staff within clinical laboratories who are uniquely positione
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 6, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out by the a
Publikováno v:
Thrombosis research. 207
Introduction Heparin-induced thrombocytopenia (HIT) is a life-threatening side effect of heparin necessitating immediate heparin discontinuation. A missed diagnosis of HIT carries significant morbidity and mortality, while overdiagnosis may result in
Publikováno v:
The journal of applied laboratory medicine. 7(2)
Background Laboratory stewardship programs aim to improve the use of laboratory resources, including reducing inappropriate testing. These programs should engage all healthcare stakeholder groups, including all levels of laboratory staff. Medical lab
Autor:
Eunike C. McGowan, Marie-France Delisle, Amanda Skoll, Catherine A. Hyland, Elona Turley, Tanya N. Nelson, Robert L. Flower, Elizna M. Schoeman, Nicholas Au, Gwen Clarke
Publikováno v:
Transfusion. 58:2260-2264
BACKGROUND: RhD DEL variants may show complete or partial expression of RhD epitopes. There have been only rare reports of anti‐D causing hemolytic disease of the fetus and newborn (HDFN) in this context. We report a case of severe HDFN associated
Autor:
Elona Turley, Mathew P. Estey, Karina Rodriguez-Capote, Trefor Higgins, Vilte E. Barakauskas, Lynne M. McKenzie, Gordon R. Bailey
Publikováno v:
Diabetes Care. 38:e154-e155
A 66-year-old Caucasian female was referred for specialist follow-up of her treatment-refractory type 2 diabetes. The diagnosis was made based on two consecutive HbA1c results >6.5% (48 mmol/mol) in accordance with the Canadian Diabetes Association a
Publikováno v:
Blood. 87:1891-1899
We investigated the ability of blood B cells, bone marrow (BM) plasma cells, and terminal leukemic plasma cells (T-PCL) from patients with multiple myeloma (MM) to migrate on extracellular matrix proteins. Hyaluronan (HA), but not collagen type I, co
Publikováno v:
Blood. 124:4185-4185
Background: Heparin-induced thrombocytopenia (HIT) is associated with anti-platelet factor-4 (PF4)/heparin antibodies that activate platelets, resulting in thrombocytopenia and a pro-thrombotic state. At our institution antibody-mediated platelet act